Logo for Algernon Pharmaceuticals Inc.
AGN
-5.56%

Algernon Pharmaceuticals Inc.

Associated Securities:
Status
ActiveT2
Issued & Outstanding28,706,219
Reserved for Issuance19,387,036
CurrencyCAD
CSE IndexNo

Quote

Last Price0.00 (0.00%)
Volume0
Change0.00
Bid Size0
Bid Price
Ask Price
Ask Size0
Prev Close
Open
Day High
Day Low
52 Week High
52 Week Low

Algernon Pharmaceuticals Inc.

Charts by TradingView

Depth Display

Recent Trades

About

Algernon Pharmaceuticals Inc.

Listing Date
February 01, 2016

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.